Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “chimeric”

309 pharma patents match "chimeric" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 309
Index total 30,257
Page 10 / 13

Quick answer

This filtered view shows 309 pharmaceutical patents matching "chimeric" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

309 results for “chimeric” · 30,257 patents in full index Clear search

  1. US 9447405

    Regulation of specific spinal neurons regulating pain transmission via chimeric toxins

    The Regents of the University of California · Granted Sep 20, 2016 · Expires Sep 15, 2036

    granted

  2. US 9439959

    Chimeric influenza virus-like particles

    Takeda Vaccines, Inc. · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted

  3. US 9359447

    Anti-mesothelin chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted

  4. US 9359437

    Antibodies comprising chimeric constant domains

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted

  5. US 9266960

    Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted

  6. US 9238799

    Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 19, 2016 · Expires Jan 14, 2036

    granted

  7. US 9139644

    Modified chimeric polypeptides with improved pharmacokinetic properties

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

  8. US 8920812

    Chimeric RSV-F polypeptide and lentivirus or alpha-retrovirus Gag-based VLPS

    Takeda Vaccines, Inc. · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted

  9. US 8906863

    Proteolysis-resistant capsid of chimeric hepatitis E virus as an oral delivery vector

    The Regents of the University of California · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted

  10. US 8822196

    Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted

  11. US 8821884

    Compositions and methods using MD-2 mutants and chimeric proteins

    The Regents of the University of California · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted

  12. US 8790639

    Enhanced antimicrobial lytic activity of a chimeric Ply187 endolysin

    The United States of America, as represented by the Secretary of Agriculture · Granted Jul 29, 2014 · Expires Jul 24, 2034

    granted

  13. US 8748591

    Chimeric sindbis-western equine encephalitis virus and uses thereof

    The Board of Regents of the University of Texas System · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  14. US 8715689

    Chimeric west nile/dengue viruses

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted May 6, 2014 · Expires May 1, 2034

    granted

  15. US 8642550

    Chimeric natriuretic peptides without hypotensive inducing capability

    Regents of the University of Minnesota · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

  16. US 8568739

    Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 29, 2013 · Expires Oct 24, 2033

    granted

  17. US 8465743

    Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 18, 2013 · Expires Jun 13, 2033

    granted

  18. US 8449884

    Clotting factor-fc chimeric proteins to treat hemophilia

    Syntonix Pharmaceuticals, Inc. · Granted May 28, 2013 · Expires May 23, 2033

    granted

  19. US 8420099

    Chimeric protein for prevention and treatment of HIV infection

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted

  20. US 8343506

    Chimeric chikungunya virus and uses thereof

    The Board of Regents of the University of Texas System · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted

  21. US 8329182

    Immunoglobulin chimeric monomer-dimer hybrids

    Syntonix Pharmaceuticals, Inc. · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted

  22. US 8287876

    Recombinant chimeric antigens for diagnosis and prevention of scrub typhus

    United States of America as represented by the Secretary of the Air Force · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted

  23. US 8232379

    Nucleic acids encoding chimeric flavivirus immunogens comprising the Japanese encephalitis virus (JEV) prM signal sequence

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Jul 31, 2012 · Expires Jul 26, 2032

    granted

  24. US 8221768

    Chimeric flavivirus immunogens comprising the Japanese encephalitis virus (JEV) prM signal sequence

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.